Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Wit Dyne Health Co., Ltd. is a leading Chinese pharmaceutical company specializing in pediatric healthcare and nutritional products. Its core subsidiary, Dain Pharmaceutical, is a dominant player in the Chinese pediatric market, best known for its flagship Vitamin AD supplement, Yikexin. The company's portfolio includes a wide range of pediatric medications for infectious diseases, respiratory conditions, and neurological disorders like ADHD and epilepsy, as well as health products such as DHA and probiotics. Listed on the Shenzhen Stock Exchange, Wit Dyne focuses on innovative drug delivery technologies tailored for children, including taste-masking and specialized formulations, and maintains a robust domestic distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WIT DYNE's Dain Pharmaceutical.